| Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation (NCT03842696) | University of Michigan Rogel Cancer Center | 2020-02-04 |
| Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma (NCT04051047) | University of Michigan Rogel Cancer Center | 2019-11-30 |
| Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) (NCT03787680) | University of Michigan Rogel Cancer Center | 2019-10-31 |
| APG-115 in Salivary Gland Cancer Trial (NCT03781986) | University of Michigan Rogel Cancer Center | 2019-10-28 |
| Acupressure for Fatigue in Ovarian Cancer Survivors (NCT03763838) | University of Michigan Rogel Cancer Center | 2019-10-07 |
| A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas (NCT03632317) | University of Michigan Rogel Cancer Center | 2019-10-01 |
| Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer (NCT03829722) | University of Michigan Rogel Cancer Center | 2019-09-05 |
| Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas (NCT00843375) | University of Michigan Rogel Cancer Center | 2019-08-07 |
| Surgical Treatment of Post-surgical Mastectomy Pain Utilizing the Regenerative Peripheral Nerve Interface (NCT04530526) | University of Michigan Rogel Cancer Center | 2019-07-12 |
| ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer (NCT03300505) | University of Michigan Rogel Cancer Center | 2019-05-31 |
| Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer (NCT03785873) | University of Michigan Rogel Cancer Center | 2019-05-22 |
| Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders (NCT03601819) | University of Michigan Rogel Cancer Center | 2019-05-15 |
| Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma (NCT03927105) | University of Michigan Rogel Cancer Center | 2019-04-25 |
| Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma (NCT03562507) | University of Michigan Rogel Cancer Center | 2019-04-11 |
| Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy (NCT03639935) | University of Michigan Rogel Cancer Center | 2019-03-28 |
| Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer (NCT03559049) | University of Michigan Rogel Cancer Center | 2018-12-24 |
| Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations (NCT03570619) | University of Michigan Rogel Cancer Center | 2018-12-14 |
| FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) (NCT03556904) | University of Michigan Rogel Cancer Center | 2018-12-10 |
| Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer (NCT03689582) | University of Michigan Rogel Cancer Center | 2018-11-13 |
| Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL) (NCT03547700) | University of Michigan Rogel Cancer Center | 2018-09-26 |
| The ConnectedCancerCare Pilot Study (CCC) (NCT03618017) | University of Michigan Rogel Cancer Center | 2018-08-08 |
| Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma (NCT03287063) | University of Michigan Rogel Cancer Center | 2018-07-05 |
| Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy (NCT03515356) | University of Michigan Rogel Cancer Center | 2018-06-13 |
| Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer (NCT03416153) | University of Michigan Rogel Cancer Center | 2018-05-21 |
| Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer (NCT03228186) | University of Michigan Rogel Cancer Center | 2018-03-05 |
| Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma (NCT03235869) | University of Michigan Rogel Cancer Center | 2018-03-01 |
| Abraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial Cancer (NCT03240016) | University of Michigan Rogel Cancer Center | 2018-02-08 |
| Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma (NCT03287050) | University of Michigan Rogel Cancer Center | 2018-01-24 |
| A Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML (NCT02973711) | University of Michigan Rogel Cancer Center | 2018-01-01 |
| Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab (NCT03286114) | University of Michigan Rogel Cancer Center | 2017-12-21 |
| The SMART CART Study: Health Information Technology (NCT04051216) | University of Michigan Rogel Cancer Center | 2017-12-20 |
| Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations (NCT03352427) | University of Michigan Rogel Cancer Center | 2017-12-06 |
| Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy (NCT03208712) | University of Michigan Rogel Cancer Center | 2017-11-01 |
| Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT03194373) | University of Michigan Rogel Cancer Center | 2017-10-12 |
| Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents (NCT03242915) | University of Michigan Rogel Cancer Center | 2017-10-03 |
| Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer (NCT03101566) | University of Michigan Rogel Cancer Center | 2017-09-08 |
| Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab (NCT03135171) | University of Michigan Rogel Cancer Center | 2017-07-26 |
| Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) (NCT02997956) | University of Michigan Rogel Cancer Center | 2017-07-01 |
| The Validation of a Novel Adherence Method for Oral Oncolytics (NCT03561272) | University of Michigan Rogel Cancer Center | 2017-06-20 |
| Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma (NCT03168152) | University of Michigan Rogel Cancer Center | 2017-05-11 |
| Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer (NCT03099356) | University of Michigan Rogel Cancer Center | 2017-04-27 |
| Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients (NCT02763033) | University of Michigan Rogel Cancer Center | 2017-04-26 |
| Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer (NCT02946008) | University of Michigan Rogel Cancer Center | 2017-03-27 |
| Phase Ib/II Trial of Interleukin-2 and PD-1 Checkpoint Inhibitor, Nivolumab In Metastatic Clear Cell Renal Cell Cancer (NCT02989714) | University of Michigan Rogel Cancer Center | 2017-03-16 |
| Functional Imaging in Lung SBRT (NCT03121300) | University of Michigan Rogel Cancer Center | 2017-02-06 |
| Genomics in Michigan Impacting Observation or Radiation (NCT02783950) | University of Michigan Rogel Cancer Center | 2017-01-17 |
| Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer (NCT07645391) | University of Michigan Rogel Cancer Center | 2017-01-01 |
| Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer (NCT02784288) | University of Michigan Rogel Cancer Center | 2016-10-31 |
| Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (NCT02677948) | University of Michigan Rogel Cancer Center | 2016-10-01 |
| A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma (NCT02805179) | University of Michigan Rogel Cancer Center | 2016-09-22 |
| Expansion Trial for Axitinib In Head And Neck Cancer (NCT02762513) | University of Michigan Rogel Cancer Center | 2016-08-30 |
| Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma (NCT02729194) | University of Michigan Rogel Cancer Center | 2016-06-01 |
| Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory Lymphoma (NCT02613598) | University of Michigan Rogel Cancer Center | 2016-05-12 |
| Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer (NCT02712437) | University of Michigan Rogel Cancer Center | 2016-03-16 |
| Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant (NCT02734797) | University of Michigan Rogel Cancer Center | 2016-03-09 |
| A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome (NCT02400463) | University of Michigan Rogel Cancer Center | 2016-02-05 |
| Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy (NCT02485470) | University of Michigan Rogel Cancer Center | 2016-02-01 |
| A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma (NCT02460835) | University of Michigan Rogel Cancer Center | 2016-01-26 |
| A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer (NCT02492867) | University of Michigan Rogel Cancer Center | 2016-01-14 |
| Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation (NCT03161665) | University of Michigan Rogel Cancer Center | 2016-01-14 |
| Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma (NCT01528865) | University of Michigan Rogel Cancer Center | 2015-12-01 |
| A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC (NCT02463994) | University of Michigan Rogel Cancer Center | 2015-10-01 |
| Early Imaging Biomarkers in NSCLC (NCT03121287) | University of Michigan Rogel Cancer Center | 2015-09-23 |
| Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations (NCT02277457) | University of Michigan Rogel Cancer Center | 2015-09-01 |
| A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers (NCT02409121) | University of Michigan Rogel Cancer Center | 2015-09-01 |
| VISmodegib for ORbital and Periocular Basal Cell Carcinoma (NCT02436408) | University of Michigan Rogel Cancer Center | 2015-07-15 |
| Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy (NCT02494453) | University of Michigan Rogel Cancer Center | 2015-06-01 |
| Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma (NCT02331368) | University of Michigan Rogel Cancer Center | 2015-06-01 |
| The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) (NCT02400190) | University of Michigan Rogel Cancer Center | 2015-05-27 |
| Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia (NCT02328755) | University of Michigan Rogel Cancer Center | 2015-01-01 |
| Quantitative MRI for Myelofibrosis (NCT01973881) | University of Michigan Rogel Cancer Center | 2014-12-22 |
| Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant (NCT01790568) | University of Michigan Rogel Cancer Center | 2014-12-01 |
| Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies (NCT02145403) | University of Michigan Rogel Cancer Center | 2014-10-01 |
| Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas (NCT02158975) | University of Michigan Rogel Cancer Center | 2014-09-01 |
| A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer (NCT02059213) | University of Michigan Rogel Cancer Center | 2014-06-01 |
| Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients (NCT02338115) | University of Michigan Rogel Cancer Center | 2014-05-01 |
| Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma (NCT02138578) | University of Michigan Rogel Cancer Center | 2014-05-01 |
| Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma (NCT01811992) | University of Michigan Rogel Cancer Center | 2014-04-01 |
| Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery (NCT02097732) | University of Michigan Rogel Cancer Center | 2014-04-01 |
| A Randomized Comparative Study of a Weekly Versus Every Other Week Nurse Practitioner-led Symptom Management Clinic for Head and Neck Cancer Patients Undergoing Concurrent Chemotherapy and Radiation (NCT02085525) | University of Michigan Rogel Cancer Center | 2014-03-01 |
| Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer (NCT02031250) | University of Michigan Rogel Cancer Center | 2014-02-01 |
| Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas (NCT02037230) | University of Michigan Rogel Cancer Center | 2014-01-01 |
| A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer (NCT02013453) | University of Michigan Rogel Cancer Center | 2013-12-01 |
| Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain (NCT01912612) | University of Michigan Rogel Cancer Center | 2013-10-30 |
| RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease. (NCT01188889) | University of Michigan Rogel Cancer Center | 2013-09-01 |
| Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer (NCT01975597) | University of Michigan Rogel Cancer Center | 2013-08-01 |
| A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease (NCT01700036) | University of Michigan Rogel Cancer Center | 2013-07-01 |
| A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors (NCT02006407) | University of Michigan Rogel Cancer Center | 2013-06-01 |
| Optimization of MRI for Radiation Therapy (NCT02045381) | University of Michigan Rogel Cancer Center | 2013-03-14 |
| A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL (NCT01750567) | University of Michigan Rogel Cancer Center | 2012-11-01 |
| Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer (NCT01700010) | University of Michigan Rogel Cancer Center | 2012-11-01 |
| Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer (NCT01642732) | University of Michigan Rogel Cancer Center | 2012-10-01 |
| Effect of Radiation on Tissue for Delayed Breast Reconstruction (NCT01666899) | University of Michigan Rogel Cancer Center | 2012-10-01 |
| Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) (NCT01663285) | University of Michigan Rogel Cancer Center | 2012-09-01 |
| A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer (NCT01663272) | University of Michigan Rogel Cancer Center | 2012-07-01 |
| Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer (NCT01633541) | University of Michigan Rogel Cancer Center | 2012-03-01 |
| Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone (NCT01428219) | University of Michigan Rogel Cancer Center | 2012-02-01 |
| Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer (NCT01477489) | University of Michigan Rogel Cancer Center | 2012-01-01 |
| Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer (NCT01469546) | University of Michigan Rogel Cancer Center | 2012-01-01 |
| A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer (NCT01986738) | University of Michigan Rogel Cancer Center | 2012-01-01 |